177 related articles for article (PubMed ID: 33165766)
1. Paclitaxel-Loaded Colloidal Silica and TPGS-Based Solid Self-Emulsifying System Interferes Akt/mTOR Pathway in MDA-MB-231 and Demonstrates Anti-tumor Effect in Syngeneic Mammary Tumors.
Meher JG; Dixit S; Singh Y; Pawar VK; Konwar R; Saklani R; Chourasia MK
AAPS PharmSciTech; 2020 Nov; 21(8):313. PubMed ID: 33165766
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-loaded TPGS enriched self-emulsifying carrier causes apoptosis by modulating survivin expression and inhibits tumour growth in syngeneic mammary tumours.
Meher JG; Dixit S; Pathan DK; Singh Y; Chandasana H; Pawar VK; Sharma M; Bhatta RS; Konwar R; Kesharwani P; Chourasia MK
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S344-S358. PubMed ID: 30282466
[TBL] [Abstract][Full Text] [Related]
3. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors.
Ye J; Liu Y; Xia X; Meng L; Dong W; Wang R; Fu Z; Liu H; Han R
Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803
[TBL] [Abstract][Full Text] [Related]
4. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.
Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y
Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272
[TBL] [Abstract][Full Text] [Related]
5. Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity.
Valicherla GR; Dave KM; Syed AA; Riyazuddin M; Gupta AP; Singh A; Wahajuddin ; Mitra K; Datta D; Gayen JR
Sci Rep; 2016 May; 6():26895. PubMed ID: 27241877
[TBL] [Abstract][Full Text] [Related]
6. Pyranocarbazole derivatives as potent anti-cancer agents triggering tubulin polymerization stabilization induced activation of caspase-dependent apoptosis and downregulation of Akt/mTOR in breast cancer cells.
Patel OPS; Arun A; Singh PK; Saini D; Karade SS; Chourasia MK; Konwar R; Yadav PP
Eur J Med Chem; 2019 Apr; 167():226-244. PubMed ID: 30772606
[TBL] [Abstract][Full Text] [Related]
7. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability.
Gao P; Rush BD; Pfund WP; Huang T; Bauer JM; Morozowich W; Kuo MS; Hageman MJ
J Pharm Sci; 2003 Dec; 92(12):2386-98. PubMed ID: 14603484
[TBL] [Abstract][Full Text] [Related]
8. Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles.
Hou J; Sun E; Zhang ZH; Wang J; Yang L; Cui L; Ke ZC; Tan XB; Jia XB; Lv H
Drug Deliv; 2017 Nov; 24(1):261-269. PubMed ID: 28165804
[TBL] [Abstract][Full Text] [Related]
9. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
[TBL] [Abstract][Full Text] [Related]
10. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.
Jain S; Jain AK; Pohekar M; Thanki K
Free Radic Biol Med; 2013 Dec; 65():117-130. PubMed ID: 23792276
[TBL] [Abstract][Full Text] [Related]
11. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response.
Pawar VK; Panchal SB; Singh Y; Meher JG; Sharma K; Singh P; Bora HK; Singh A; Datta D; Chourasia MK
J Control Release; 2014 Dec; 196():295-306. PubMed ID: 25459427
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer.
Kim JE; Park YJ
Int J Nanomedicine; 2017; 12():645-658. PubMed ID: 28176896
[TBL] [Abstract][Full Text] [Related]
14. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Surfactant on Paclitaxel Nanocrystals: An In Vitro and In Vivo Study.
Liu H; Ma Y; Liu D; Fallon JK; Liu F
J Biomed Nanotechnol; 2016 Jan; 12(1):147-53. PubMed ID: 27301180
[TBL] [Abstract][Full Text] [Related]
16. Liposils: An effective strategy for stabilizing Paclitaxel loaded liposomes by surface coating with silica.
Ingle SG; Pai RV; Monpara JD; Vavia PR
Eur J Pharm Sci; 2018 Sep; 122():51-63. PubMed ID: 29936087
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity.
Monteiro LOF; Fernandes RS; Castro L; Reis D; Cassali GD; Evangelista F; Loures C; Sabino AP; Cardoso V; Oliveira MC; Branco de Barros A; Leite EA
Mol Pharm; 2019 Aug; 16(8):3477-3488. PubMed ID: 31257891
[TBL] [Abstract][Full Text] [Related]
19. [Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].
Wang YZ; Fang XL; Li YJ; Zhang ZW; Han LM; Sha XY
Yao Xue Xue Bao; 2008 Jun; 43(6):640-6. PubMed ID: 18822969
[TBL] [Abstract][Full Text] [Related]
20. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
